{"name": "Variation Biotechnologies (US)",
 "permalink": "variation-biotechnologies-us",
 "crunchbase_url": "http://www.crunchbase.com/company/variation-biotechnologies-us",
 "homepage_url": "http://www.vbivaccines.com",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": 2001,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "info@VBIvaccines.com",
 "phone_number": "617-830-3031",
 "description": "",
 "created_at": "Thu Jun 13 12:42:11 UTC 2013",
 "updated_at": "Thu Jun 13 12:43:18 UTC 2013",
 "overview": "\u003Cp\u003EVBI is dedicated to the innovative formulation, development and delivery of safe and effective vaccines that expand and enhance vaccine protection in both established and emerging markets. VBI\u2019s innovative approach to vaccine development and growing pipeline of vaccine programs address significant market opportunities and are designed to answer critical unmet medical needs.\u003C/p\u003E\n\n\u003Cp\u003EFounded in 2001, VBI is a privately held company headquartered in Cambridge, Massachusetts, with research facilities in Ottawa, Canada. The company\u2019s investors include Clarus Ventures, ARCH Venture Partners and 5AM Ventures.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       115],
      "assets/images/resized/0027/4815/274815v1-max-150x150.png"],
     [[198,
       153],
      "assets/images/resized/0027/4815/274815v1-max-250x250.png"],
     [[198,
       153],
      "assets/images/resized/0027/4815/274815v1-max-450x450.png"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "CEO",
    "person":
     {"first_name": "Jeff",
      "last_name": "Baxter",
      "permalink": "jeff-baxter",
      "image": null}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$751k",
 "funding_rounds":
  [{"round_code": "debt_round",
    "source_url": "http://www.sec.gov/Archives/edgar/data/1525594/000152559413000001/xslFormDX01/primary_doc.xml",
    "source_description": "SEC",
    "raised_amount": 751061.0,
    "raised_currency_code": "USD",
    "funded_year": 2013,
    "funded_month": 3,
    "funded_day": 8,
    "investments":
     []}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "222 Third Street",
    "address2": "Suite 2241",
    "zip_code": "02142",
    "city": "Cambridge",
    "state_code": "MA",
    "country_code": "USA",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [],
 "external_links":
  []}